MedCity News

What the ‘One Nation, Overcharged’ Campaign Aims to Achieve

Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer

Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer.

By Frank Vinluan

Devices & Diagnostics

Paper Craft Purple Human Brain on Purple Background Front View.

CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery

CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027.

By Katie Adams

MedCity Influencers

The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing

Millennials and Gen Z are more likely to engage earlier, seek care proactively, and continue treatment over time. A mental health diagnosis is more likely to represent active management, not a late-stage recognition of a problem that has already compounded.

By Mark Newman

Latest Video

Latest News

Policy

Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices

MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics.

By Stephanie Baum

MedCity Influencers

Kill the Clipboard Tax

Replacing a paper clipboard with a QR code on your phone doesn’t kill the clipboard; it’s just a better clipboard. Why? The burden is still on the patient. It's the digital version of carrying a manila folder of records across town. This is a half-measure. It's not true interoperability.

By Jason Prestinario

The Power of Real World Data to Study Women’s Health at Scale

Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!

By Veradigm and MedCity News

MedCity Influencers

AI in Drug Discovery: Surveying the Breadth of the Challenges

AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are those that stay grounded, set realistic expectations, and keep experienced scientists at the center of decisions that require genuine creativity and judgment.

By Peter Tummino

Is Your Healthcare Organization Ready to Implement AI?

A checklist for AI readiness from Nordic aims to help healthcare organizations avoid failure.

By Stephanie Baum

BioPharma, Legal

Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was

Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology.

By Frank Vinluan

The Power Behind Enterprise EHR Software for Large Healthcare Systems

Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.

By Malvika Tarnekar, Director of Product Strategy, PrognoCIS by Bizmatics Inc

Consumer / Employer

Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment

Peterson Philanthropies launched Peterson Health Analytics with a $50 million commitment to help employers better understand and manage healthcare costs.

By Marissa Plescia

Artificial Intelligence

Clear emergency exit sign featuring a green running figure and left arrow, mounted on a textured gray wall, conveying safety and guidance.

What Will the Next Healthcare Exit Winners Look Like?

Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models.

By Katie Adams

MedCity Influencers

New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research Hospitals Can Seize the Moment

Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For any hospital considering adopting these new solutions, here are some of the key questions and considerations that should be top of mind.

By Richard Yeatman

MedCity Influencers

Building the Backbone of Rural Health: Meeting the Reality on the Ground

Rural healthcare has always run on ingenuity, resilience, and community trust. What has too often been missing is the infrastructure strong enough to match that and sustain it at scale. That is what makes this moment different.

By Taylor Justice

MedCity Influencers

The Celiac Care Gap Begins After Diagnosis

Portable gluten detection tools are not a substitute for standard care. Used carefully, they may help clinicians support patients when hidden gluten exposure remains a problem.

By Dr. Jignesh Shah

BioPharma, Startups, Health Tech

Novellia Snags $18M for Its Real-World Data Platform

Novellia raised $18 million in Series A funding to scale its platform, which helps patients consolidate medical records and share anonymized data with pharma companies. CEO Shashi Shankar argued that sourcing data directly from patients can create more complete healthcare datasets and improve drug research.

By Katie Adams

Health Tech

Ilant Health Raises $15M to Advance Obesity Care

Ilant Health's Series A round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, Celtic, LifeX and AlphaLab.

By Marissa Plescia

BioPharma, Pharma

FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug

Fulcrum Therapeutics drug pociredir posted early clinical trial results showing signs of treating sickle cell disease with no reports of serious complications. But the biotech is discontinuing this program due to FDA concerns that drugs in this class of medicines raise the risk of cancer.

By Frank Vinluan

MedCity Influencers

What Data Delays Are Costing Healthcare — And Its Patients

Timely, usable data closes care gaps and improves operations, but healthcare organizations lack access.

By Robbins Schrader